Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study
… While animal studies strongly suggest that treatment of Type 2 diabetes with dipeptidyl-peptidase IV inhibitors (DPP-4i) is protective for heart failure (HF), early clinical studies have …..... Read More